Concepedia
Statistics
Publications
16
Citations
2.3K
H-Index
14
Active since
2005
Affiliations
Merck KGaA, Darmstadt (Germany)(Current)
Washington University in St. Louis
Ono Pharmaceutical (United States)
Tennessee Oncology
National Cancer Institute
Lisa Mahnke is an author at Merck KGaA, Darmstadt (Germany) specializing in pharmacology, medicine, and metastasis.
Publications per year
2005–2020
Avelumab in patients with chemotherapy-refractory metastatic Merkel cell carcinoma: a multicentre, single-group, open-label, phase 2 trial
Howard L. Kaufman, Jeffery S. Russell, Omid Hamid et al. · The Lancet Oncology · 2016 · 1.2K citations · Full text
Medicine, Oncology, Pharmacology +11
Phase I Trial of M7824 (MSB0011359C), a Bifunctional Fusion Protein Targeting PD-L1 and TGFβ, in Advanced Solid Tumors
Julius Strauss, Christopher R. Heery, Jeffrey Schlom et al. · Clinical Cancer Research · 2018 · 415 citations · Full text
Medicine, Oncology, Pharmacology +17
Combination Therapy With Telaprevir for Chronic Hepatitis C Virus Genotype 1 Infection in Patients With HIV
Mark Sulkowski, Kenneth E. Sherman, Douglas T. Dieterich et al. · Annals of Internal Medicine · 2013 · 200 citations
Pharmacy, Clinical Pharmacokinetics, Pharmacotherapy +12
Real-world treatment outcomes in patients with metastatic Merkel cell carcinoma treated with chemotherapy in the USA
C. Lance Cowey, Lisa Mahnke, Janet L. Espirito et al. · Future Oncology · 2017 · 116 citations · Full text
Medicine, Oncology, Chemotherapy +15
Evaluation of real-world treatment outcomes in patients with distant metastatic Merkel cell carcinoma following second-line chemotherapy in Europe
Jürgen C. Becker, Eva Lorenz, Selma Ugurel et al. · Oncotarget · 2017 · 91 citations · Full text
Medicine, Dermatology, Oncology +17
1–5 of 16